Bio-Techne Corp
Ownership
Ownership Structure
Who owns Bio-Techne Corp (TECH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.6% of the shares are freely tradable; institutional investors hold 117.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.94 | 14,025,816 | +14.4 | 06/30/2026 |
| FMR Inc | 8.16 | 12,794,784 | +62.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 6.52 | 10,218,558 | +0.4 | 06/30/2026 |
| The Goldman Sachs Group Inc | 4.68 | 7,343,324 | +277.8 | 06/30/2026 |
| HBK INVESTMENTS L P | 4.35 | 6,825,000 | +0.0 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 4.15 | 6,506,360 | +0.4 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 4.07 | 6,374,717 | -25.3 | 06/30/2026 |
| State Street Corp | 3.81 | 5,980,370 | +1.9 | 06/30/2026 |
| Geode Capital Management, LLC | 3.41 | 5,351,464 | +4.7 | 06/30/2026 |
| Amvescap Plc. | 3.18 | 4,986,424 | +8.7 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Hippel James | CFO | 170,183 | 12,372,304 $ | Aug 15, 2026 | direct |
| Kelderman Kim | Chief Executive Officer | 82,762 | 6,016,797 $ | Aug 15, 2026 | direct |
| Higgins John L | Director | 77,254 | 5,616,366 $ | Sep 28, 2026 | direct |
| Baumgartner Robert V | Director | 56,884 | 4,135,467 $ | Sep 22, 2026 | direct |
| Geist William | PRESIDENT, PROTEIN SCIENCES | 24,943 | 1,813,356 $ | Aug 15, 2026 | direct |
| Bohnen Shane | SVP - General Counsel | 10,360 | 753,172 $ | Aug 15, 2026 | direct |
| Crouse Steven C. | President - Diag & Spatial Bi | 10,237 | 744,230 $ | Aug 15, 2026 | direct |
| Herr Amy E. | Director | 576 | 41,875 $ | Aug 15, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Higgins John L | Director | Other | 5,562 | 72.51 | 403,301 |
| Sep 28, 2026 | Higgins John L | Director | Other | 15,940 | 0.00 | – |
| Sep 22, 2026 | Baumgartner Robert V | Director | Other | 5,559 | 72.55 | 403,305 |
| Sep 22, 2026 | Baumgartner Robert V | Director | Other | 15,940 | 0.00 | – |
| Aug 15, 2026 | Kelderman Kim | Chief Executive Officer | Other | 10,821 | 72.40 | 783,440 |
| Aug 15, 2026 | Kelderman Kim | Chief Executive Officer | Other | 21,470 | 0.00 | – |
| Aug 15, 2026 | Hippel James | CFO | Other | 4,310 | 72.40 | 312,044 |
| Aug 15, 2026 | Hippel James | CFO | Other | 9,779 | 0.00 | – |
| Aug 15, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | Other | 1,976 | 72.40 | 143,062 |
| Aug 15, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | Other | 6,416 | 0.00 | – |
| Aug 15, 2026 | Bohnen Shane | SVP - General Counsel | Other | 1,343 | 72.40 | 97,233 |
| Aug 15, 2026 | Bohnen Shane | SVP - General Counsel | Other | 4,350 | 0.00 | – |
| Aug 15, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | Other | 1,947 | 72.40 | 140,963 |
| Aug 15, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | Other | 5,423 | 0.00 | – |
| Aug 15, 2026 | Herr Amy E. | Director | Other | 213 | 72.40 | 15,421 |
| Aug 15, 2026 | Herr Amy E. | Director | Other | 589 | 0.00 | – |
| Jul 29, 2026 | Hippel James | CFO | Other | 51,024 | 72.03 | 3,675,259 |
| Jul 29, 2026 | Hippel James | CFO | Other | 62,068 | 47.60 | 2,954,437 |
| Jul 28, 2026 | Kelderman Kim | Chief Executive Officer | Other | 28,686 | 72.07 | 2,067,400 |
| Jul 28, 2026 | Kelderman Kim | Chief Executive Officer | Other | 35,000 | 47.60 | 1,666,000 |
| Jul 23, 2026 | Bohnen Shane | SVP - General Counsel | Other | 344 | 71.77 | 24,689 |
| Jul 23, 2026 | Bohnen Shane | SVP - General Counsel | Other | 448 | 47.60 | 21,325 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.